SEARCH

SEARCH BY CITATION

References

  • 1
    Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 1998;339: 313320.
  • 2
    Morrison JJ, Rennie JM. Clinical, scientific and ethical aspects of fetal and neonatal care at extremely preterm periods of gestation. Br J Obstet Gynaecol 1997;104: 13311350.
  • 3
    Joseph KS, Kramer MS, Marcoux S, et al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med 1998;339: 14341439.
  • 4
    Liggins GC, Howie RN. A controlled trial of antepartum corticosteroid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50: 515525.
  • 5
    Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials [see comments]. Br J Obstet Gynaecol 1990: 97: 1125.
  • 6
    Crowley P. Prophylactic corticosteroids for preterm birth [Cochrane Review]. Cochrane Library 2001; (3) Oxford.
  • 7
    Kay HH, Bird IM, Coe CL, Dudley DJ. Antenatal steroid treatment and adverse fetal effects: what is the evidence?. J Soc Gynecol Invest 2000;7: 269278.
  • 8
    Walfisch A, Hallak M, Mazor M. Multiple courses of antenatal steroids: risks and benefits. Obstet Gynecol 2001;98: 491497.
  • 9
    Dawes GS, Serra-Serra V, Moulden M, Redman CW. Dexamethasone and fetal heart rate variation. Br J Obstet Gynaecol 1994;101: 675679 (August).
  • 10
    Derks JB, Mulder EJ, Visser GH. The effects of maternal betamethasone administration on the fetus. Br J Obstet Gynaecol 1995;102: 4046 (January).
  • 11
    Magee LA, Dawes GS, Moulden M, Redman CW. A randomised controlled comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. Br J Obstet Gynaecol 1997;104: 12331238 (November).
  • 12
    Wallace EM, Baker LS. Effect of antenatal betamethasone administration on placental vascular resistance. Lancet 1999;353: 14041407.
  • 13
    Chitrit Y, Caubel P, Herrero R, Schwinte AL, Guillaumin D, Boulanger M. Effects of maternal dexamethasone administration on fetal Doppler flow velocity waveforms. Br J Obstet Gynaecol 2000;107: 501507 (April).
  • 14
    Piazze JJ, Anceschi MM, La Torre R, Amici F, Maranghi L, Cosmi EV. Effect of antenatal betamethasone therapy on maternal–fetal Doppler velocimetry. Early Hum Dev 2001;60: 225232.
  • 15
    Clifton VL, Read MA, Leitch IM, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal–placental circulation. J Clin Endocrinol Metab 1994;76: 666669.
  • 16
    Fowler NO, Chou DH. Potentiation of smooth muscle contraction by adrenal steroids. Circ Res 1961;9: 153156.
  • 17
    Whitworth JA, Connell JMC, Lever AF, Fraser R. Pressor responsiveness in steroid-induced hypertension in man. Clin Exp Pharmacol Physiol 1986;13: 353358.
  • 18
    Ullian ME. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 1999;41: 5564.
  • 19
    Miyahara H, Imayama S, Hori Y, Suzuki H. Cellular mechanisms of the steroid-induced vascular responses in the rabbit ear artery. Gen Pharmacol 1993;24: 11551162.
  • 20
    Walker BR, Williams BC. Corticosteroids and vascular tone: mapping the messenger maze. Clin Sci 1992;82: 597605.
  • 21
    Kornel L, Nelson WA, Manisundaram B, Chigurupati R, Hayashi T. Mechanism of the effects of corticosteroids and mineralocorticoids on vascular smooth muscle contractility. Steroids 1993;58(12):580587.
  • 22
    Brem AS, Bina RB, Mehta S, Marshall J. Corticosteroids inhibit the expression of calcium-dependent potassium channels in vascular smooth muscle. Mol Genet Metab 1999;67(1):5357.
  • 23
    Nambi P, Pullen M, Wu HL, Nuthulaganti P, Elshourbagy N, Kumar C. Dexamethasone down-regulates the expression of endothelin receptor in vascular smooth muscle cells. J Biol Chem 1992;267(27):19,55519,559.
  • 24
    Clifton VL, Read MA, Leitch IM, Boura ALA, Robinson PJ, Smith R. Corticotrophin-releasing hormone-induced vasodilation in the human fetal placental circulation. J Clin Endocrinol Metab 1994;79(2):666669.
  • 25
    Marinoni E, Korbrits C, Di Iorio R, Cosmi EV, Challis JRG. Effect of betamethasone in vivo on placental corticotrophin-releasing hormone in human pregnancy. Am J Obstet Gynecol 1998;178: 770778.
  • 26
    Boersma JL, Janzen KM, Oliveira L, Crankshaw DJ. Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro. Br J Pharmacol 1999;128: 15051512.
  • 27
    Bertrand C, St-Louis J. Reactivities to serotonin and histamine in umbilical and placental vessels during the third trimester after normotensive pregnancies and pregnancies complicated by preeclampsia. Am J Obstet Gynecol 1999;180: 650659.
  • 28
    Haugen G. The influence of ciclosporine A on the vasoactive effects of serotonin in in vitro perfused human umbilical arteries. Early Hum Dev 2002;67: 6977.
  • 29
    Wild SM. Betamethasone in threatened preterm labour. Lancet 2001;358: 1017.
  • 30
    Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173: 254262.